Halda Therapeutics Opco, Inc.
Clinical trials sponsored by Halda Therapeutics Opco, Inc., explained in plain language.
-
New pill HLD-0915 takes on tough prostate cancer
Disease control Recruiting nowThis study tests an experimental oral drug called HLD-0915 in men with metastatic prostate cancer that has worsened after other treatments. The trial has two phases: Phase 1 checks safety and the best dose, while Phase 2 looks at how well it controls the cancer. About 190 men wil…
Phase: PHASE1, PHASE2 • Sponsor: Halda Therapeutics OpCo, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New hope for advanced breast cancer: experimental drug HLD-0117 enters human testing
Disease control Recruiting nowThis early-phase study tests a new drug called HLD-0117 in about 33 women with a type of advanced breast cancer (ER-positive) that has spread and stopped responding to standard therapies. The main goals are to check the drug's safety and find the right dose, while also seeing if …
Phase: PHASE1 • Sponsor: Halda Therapeutics OpCo, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC